000 | 01977 a2200565 4500 | ||
---|---|---|---|
005 | 20250516021400.0 | ||
264 | 0 | _c20110616 | |
008 | 201106s 0 0 eng d | ||
022 | _a1872-6623 | ||
024 | 7 |
_a10.1016/j.pain.2010.12.014 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBoroujerdi, Amin | |
245 | 0 | 0 |
_aCalcium channel alpha-2-delta-1 protein upregulation in dorsal spinal cord mediates spinal cord injury-induced neuropathic pain states. _h[electronic resource] |
260 |
_bPain _cMar 2011 |
||
300 |
_a649-655 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 |
_aAmines _xtherapeutic use |
650 | 0 | 4 |
_aAnalgesics _xtherapeutic use |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCalcium Channels _xgenetics |
650 | 0 | 4 | _aCalcium Channels, L-Type |
650 | 0 | 4 |
_aCyclohexanecarboxylic Acids _xtherapeutic use |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGabapentin |
650 | 0 | 4 |
_aHyperalgesia _xetiology |
650 | 0 | 4 |
_aMotor Activity _xdrug effects |
650 | 0 | 4 |
_aNeuralgia _xdrug therapy |
650 | 0 | 4 |
_aOligodeoxyribonucleotides, Antisense _xpharmacology |
650 | 0 | 4 | _aPain Measurement |
650 | 0 | 4 |
_aPain Threshold _xdrug effects |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aRecovery of Function |
650 | 0 | 4 |
_aSpinal Cord _xdrug effects |
650 | 0 | 4 |
_aSpinal Cord Injuries _xcomplications |
650 | 0 | 4 | _aStatistics as Topic |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
650 | 0 | 4 |
_agamma-Aminobutyric Acid _xtherapeutic use |
700 | 1 | _aZeng, Jun | |
700 | 1 | _aSharp, Kelli | |
700 | 1 | _aKim, Donghyun | |
700 | 1 | _aSteward, Oswald | |
700 | 1 | _aLuo, David Z | |
773 | 0 |
_tPain _gvol. 152 _gno. 3 _gp. 649-655 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.pain.2010.12.014 _zAvailable from publisher's website |
999 |
_c20521890 _d20521890 |